BlackRock Institutional Trust’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$10.9M Buy
831,324
+748
+0.1% +$9.8K ﹤0.01% 2346
2016
Q3
$14.3M Buy
830,576
+79,227
+11% +$1.37M ﹤0.01% 2111
2016
Q2
$13.6M Buy
751,349
+37,108
+5% +$670K ﹤0.01% 2098
2016
Q1
$13.6M Buy
714,241
+9,979
+1% +$189K ﹤0.01% 2065
2015
Q4
$18.8M Buy
704,262
+48,848
+7% +$1.3M ﹤0.01% 1911
2015
Q3
$16M Buy
655,414
+170,638
+35% +$4.16M ﹤0.01% 1984
2015
Q2
$15.1M Buy
484,776
+215,701
+80% +$6.72M ﹤0.01% 2110
2015
Q1
$3.92M Buy
269,075
+51,736
+24% +$753K ﹤0.01% 2832
2014
Q4
$2.19M Sell
217,339
-2,828
-1% -$28.4K ﹤0.01% 3057
2014
Q3
$1.83M Buy
220,167
+21,979
+11% +$183K ﹤0.01% 3104
2014
Q2
$2.44M Buy
+198,188
New +$2.44M ﹤0.01% 3092